Evotec CSO: BMS Opt In On CNS Compound ‘Augurs Well’ For Discovery Pact

Brings Bristol Myers Additional Program Rights In Neurodegenerative Diseases.

 
• By Sten Stovall
EVT8683 is the CNS discovery alliance’s most advanced program • Source: Alamy

More from Business

More from Scrip